Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6500
+0.0600 (3.77%)
NASDAQ · Last Trade: Dec 24th, 9:57 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors